
Verrica Pharmaceuticals: A clinical-stage company developing topical treatments for skin diseases in the US.
Founded with a mission to improve the lives of individuals suffering from dermatological conditions, Verrica Pharmaceuticals is a clinical-stage medical dermatology company. The company focuses on developing and manufacturing topical treatments for skin diseases, including molluscum contagiosum. Verrica aims to provide safe, effective, and accessible therapies to patients and healthcare providers across the United States.
Notable figures affiliated with Verrica Pharmaceuticals include experienced professionals in the pharmaceutical and dermatology sectors. The company has achieved significant milestones, including advancing its lead product candidates through various stages of clinical trials. By focusing on innovative solutions for skin diseases, Verrica has made a meaningful impact on the dermatology field, offering hope and improved quality of life to patients.

VeraDermics
veradermics.com

Veru
verupharma.com

Ivrea Pharmaceuticals

Skinvisible
skinvisible.com

Vilacto Bio
vilacto.com

Vyne Therapeutics

Novelix Pharmaceuticals

Arcutis Biotherapeutics
arcutis.com

Topica Pharmaceuticals

Veralox Therapeutics
veralox.com

DermBiont
dermbiont.com

PellePharm
pellepharm.com

VeraMorph
veramorph.com

Vertice Pharma

Verda Bio
verdabio.com
Companies similar to Verrica Pharmaceuticals include VeraDermics, Veru, Ivrea Pharmaceuticals and Skinvisible.
Verrica Pharmaceuticals was founded in 2013.
Verrica Pharmaceuticals' headquarters is located in West Chester, PA, US.
Verrica Pharmaceuticals' most recent funding round was for $50M (USD) in July 2023.
As of Jul 24, 2023, Verrica Pharmaceuticals has raised a total of $112.5M (USD).
Verrica Pharmaceuticals has 46 employees as of Feb 6, 2024.